Related Experiment Video
Updated: Aug 9, 2026

Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells
Published on: May 22, 2014
[Interleukin-6 acts in different ways via soluble and membrane-bound receptors]
1Genetikai, Sejt- és Immunbiológiai Intézet, Semmelweis Orvostudományi Egyetem, Budapest.
Insights
Interleukin-6 (IL-6) signaling is less effective through soluble receptors than membrane-bound ones in liver cells. Soluble receptors alone can also activate gene expression, suggesting complex roles in disease.
Area of Science:
- Immunology
- Cell Biology
- Biochemistry
Context:
- Interleukin-6 (IL-6) is a key cytokine regulating immune and physiological processes.
- IL-6 exerts its effects through a receptor complex involving a ligand-specific chain and gp130.
- Soluble forms of the IL-6 receptor exist in body fluids and can interact with membrane-bound components.
Purpose:
- To investigate the differential effects of IL-6 via membrane-bound versus soluble receptors.
- To compare IL-6 action on HepG2 human hepatoma and primary rat hepatocytes.
- To analyze early (junB mRNA) and late (fibrinogen protein) markers of IL-6 signaling.
Summary:
- IL-6 demonstrated reduced efficacy when signaling through soluble receptors compared to membrane-bound receptors in both cell types.
- The expression of the protooncogene junB was induced by IL-6 via both receptor types, but more strongly via membrane-bound receptors.
- Soluble IL-6 receptors, independently of IL-6, were found to induce junB gene expression.
Impact:
- These findings reveal distinct signaling efficiencies of IL-6 through different receptor forms.
- The independent activity of soluble receptors suggests novel mechanisms in IL-6-mediated cellular responses.
- Understanding these pathways may offer insights into the pathogenesis of IL-6-related diseases.
Abstract:
Interleukin-6 is a multifunctional cytokine participating in the regulation of several immunologic and other cell-physiological phenomena. It acts via a receptor consisting of two components, that besides the ligand-specific chain also contains a second component of 130 kD (gp 130). The soluble form of the ligand-specific component of this receptor was shown to occur physiologically in body fluids and -following the binding of interleukin-6-to be capable of associating with the membrane-bound receptor component and inducing signal-transduction. We studied the possible differences between the effects of interleukin-6 exerted via membrane-bound or soluble receptors on HepG2 human hepatoma and primary rat hepatocyte cultures. We used two methods to study the action of interleukin-6: the mRNA expression of the protooncogene junB as an early marker, and the protein production of fibrinogen as a late one. The effect of interleukin-6 on both cell types examined with both methods used was lower via the soluble than the membrane-bound receptor. In addition, the soluble receptors alone (without interleukin-6) could induce the expression of the junB gene. Considering the wide-spread biological and pathological activities of interleukin-6 these phenomena could have some role in the pathogenesis of some diseases.
Related Concept Videos
Cell-surface Signaling
Types of Signaling Molecules
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Insulin: The Receptor and Signaling Pathways

